Skanray Technologies IPO Details:
Contents
- 1 When is Skanray Technologies IPO Launching?
- 2 Skanray Technologies IPO Tentative Timetable
- 3 Skanray Technologies IPO Lot Size
- 4 Skanray Technologies IPO Date & Price Band (Tentative)
- 5 Skanray Technologies IPO Share Price
- 6 Skanray Technologies IPO Promoter Holding
- 7 Skanray Technologies Board Directors
- 8 Skanray Technologies Company Financials
- 9 About Skanray Technologies:
- 10 Company Contact Information
- 11 Skanray Technologies IPO Registrar
- 12 Skanray Technologies IPO Lead Managers
- 13 Skanray Technologies IPO Gray Market Price (GMP)
- 14 How to Apply For Skanray Technologies IPO?
- 15 Final Review of Skanray Technologies IPO
When is Skanray Technologies IPO Launching?
Skanray Technologies IPO date might be in October 2021 as the company got approval from the SEBI recently.
Skanray Technologies IPO Tentative Timetable
The Skanray Technologies IPO date is October 2021 and the IPO close date is October 2021. The allotment date is October 2021 and the IPO may list in November 2021.
| Price Band Announcement: | October 2021 |
| Anchor Investors Allotment: | October 2021 |
| IPO Open Date: | October 2021 |
| IPO Close Date: | October 2021 |
| Basis of Allotment: | October 2021 |
| Refunds: | October 2021 |
| Credit to Demat Account: | October 2021 |
| IPO Listing Date: | November 2021 |
Skanray Technologies IPO Lot Size
The Skanray Technologies IPO minimum market lot is – shares with ₹- application amount. The retail investors can apply up-to – lots, – shares with ₹- application amount.
| Minimum Lot Size: | Minimum – Shares for 1 lot |
| Minimum Amount: | ₹- for 1 lot |
| Maximum Lot Size: | Maximum – Shares for – lot |
| Maximum Amount: | ₹- for – lot |
Skanray Technologies IPO Date & Price Band (Tentative)
| IPO Open: | October 2021 |
| IPO Close: | October 2021 |
| IPO Size: | Approx ₹- Crore |
| Fresh Issue: | Approx ₹400 Crore |
| Offer for Sale: | Approx 14,106,347 Equity Shares |
| Face Value: | ₹10 Per Equity Share |
| Price Band: | ₹- to ₹- Per Share |
| Listing on: | BSE & NSE |
| Retail Quota: | 10% |
| QIB Quota: | 75% |
| NII Quota: | 15% |
| DRHP Draft Prospectus: | |
| RHP Draft Prospectus: |
As of now only the face value has been disclosed which is Rs. 10 per equity share.
Skanray Technologies IPO Promoter Holding
- Vishwaprasad Alva
- Agnus Capital LLP
- Chayadeep Properties Private Limited
- Skanray Healthcare Partners LLP
Skanray Technologies Board Directors
- Vishwaprasad Alva – Managing Director
- Balasubramanian K – Executive Director
- Deepak Komaregowda – Nominee Director
- D A Prasanna – Independent Director
- Reena Pandey – Independent director
- Harish Hassan Visweswara – Independent Director
- Jayashree Satagopan – Additional Director (Independent)
Skanray Technologies Company Financials
| Summary of financial Information (Restated Consolidated) | |||||
| Particulars | For the year/period ended (₹ in Millions) | ||||
| 31-Dec-20 | 31-Mar-20 | 31-Mar-19 | 31-Mar-18 | ||
| Total Assets | 3,485.50 | 2,755.41 | 2,866.01 | 2,675.55 | |
| Total Revenue | 3,505.19 | 1,531.02 | 1,669.22 | 1,419.90 | |
| Profit After Tax | 1,327.30 | 37.61 | (294.19) | (233.23) | |
About Skanray Technologies:
Established in 2007, Skanray Technologies is one of the central participants in the Indian medical device market. The organization is occupied with the designing, development, manufacturing, and marketing of medical devices. The organization has a differentiated portfolio of products that can be ordered into three general classifications –
- Critical care products,
- Radiology products,
- Respiratory management frameworks.
The organization has an in-house R&D group that has been allowed 27 patents, 49 trademarks, and 11 design registrations as of December 31, 2020. The organization’s products are created in-house and in light of organization’s claimed protected innovation. In Fiscal 2020 Skanray Technologies offered its products and administrations to more than 1,830 clients in 20 nations.
As of December 31, 2020, the organization has 5 manufacturing facilities, 2 in India, 2 in Italy, and 1 in the Netherland with a joined creation limit of 54,200 units for every year. Every one of the five facilities essentially fabricates US FDA and CE-certified products. The organization likewise mutually claims a testing office in Mysore (India) along with the state government and different entities.
Company Contact Information
Skanray Technologies Limited
Plot No 15-17
Hebbal Industrial Area,
Mysore – 570 016,
Phone: +91 821 241 5559
Email: investors@skanray.com
Website: https://www.skanray.com/
Skanray Technologies IPO Registrar
Link Intime India Private Limited
C-101, 1st Floor, 247 Park
Lal Bahadur Shastri Marg
Vikhroli (West)
Mumbai 400 083, Maharashtra
Telephone: +91 22 4918 6200
E-mail: skanray.ipo@linkintime.co.in
Website: www.linkintime.co.in
Investor grievance e-mail: skanray.ipo@linkintime.co.in
Contact person: Shanti Gopalkrishnan
SEBI Registration No.: INR000004058
Skanray Technologies IPO Lead Managers
- ICICI Securities Limited
- Motilal Oswal Investment Advisors Pvt Ltd
- Nomura Financial Advisory And Securities (India) Pvt Ltd
Skanray Technologies IPO Gray Market Price (GMP)
In IPO, the GMP or the Gray Market Premium is the premium sum at which the IPO shares are exchanged prior to getting recorded in the stock market. The GMP has not been uncovered at this point.
30th November 2021: 0 INR
How to Apply For Skanray Technologies IPO?
You can apply for Skanray Technologies IPO through ASBA accessible in your bank account. Simply go to the online bank login and apply by means of your bank account by selecting the Skanray Technologies IPO in the Invest segment.
UPI IPO application is offered by representatives who don’t offer banking administrations. Peruse more insight concerning applying IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank, and SBI Bank.
Final Review of Skanray Technologies IPO
The organization is a central member in the developing healthcare and medical device market in India and it holds a wide portfolio of around the world certified portfolio of products. They have a solid spotlight on R&D and have solid manufacturing capabilities. They have broad dissemination organization and great client connections and even have an accomplished administration group.
More Articles: Financial Solving
